Health
Measles is Likely to Become Endemic - NanoViricides Is Testing a Drug to Combat It
SHELTON, CT / ACCESS Newswire / April 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology ...
About this update from Nanoviricides, Inc.
[{"type":"text","content":"SHELTON, CT / ACCESS Newswire / April 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, provides further details on its Measles drug development program herewith.","length":366,"tagName":"p"},{"type":"text","content":"Measles is likely to become endemic in the USA, according to modeling conducted by Stanford scientists (https://med.stanford.edu/news/all-news/2025/04/measles-vaccination.html). The model primarily bases this conclusion on the declining rates of measles vaccination in the USA, especially since the COVID-19 pandemic. If the vaccination rates continue to decline, measles virus could become endemic, that is circulating in the population, within a few years.","length":458,"tagName":"p"},{"type":"text","content":"To date, only effective drugs have brought or maintained endemic or circulating viruses under control. There are no vaccines for herpes viruses, HIV or hepatitis C virus. Yet, successful drugs have helped patients to be cured (HCV), or recover from episodes (HSV), or at least maintain healthy lifespan (HIV) without any vaccines.","length":330,"tagName":"p"},{"type":"text","content":""We believe we already have a drug that is very likely to be effective against measles virus," said Anil R. Diwan, PhD, President and Executive Chairman of the Company, explaining, "NV-387 is a first-ever broad-spectrum antiviral that is capable of attacking over 90-95% of human pathogenic viruses; and that includes paramyxoviruses such as RSV and Measles virus."","length":385,"tagName":"p"},{"type":"text","content":""We have acquired the Measles virus and we have now completed growing the virus in the small quantities required for conducting an animal model study," added Dr. Diwan, "We can now determine how effective NV-387 would be against the Measles virus. We are highly enthused to perform this study by the fact that NV-387 was able to cure lethal lung infection by the related RSV in an animal model. There is currently no drug for RSV or for Measles, and NV-387 could work against both viruses!"","length":510,"tagName":"p"},{"type":"text","content":"The Company has its own BSL2 Virology lab...